295 related articles for article (PubMed ID: 33975846)
1. Intravenous immunoglobulin in COVID-19 associated Guillain-Barré syndrome in pregnancy.
Garcia JJ; Turalde CW; Bagnas MA; Anlacan VM
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33975846
[TBL] [Abstract][Full Text] [Related]
2. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
[TBL] [Abstract][Full Text] [Related]
3. Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report.
Kang M; Seok HY
J Korean Med Sci; 2022 May; 37(20):e160. PubMed ID: 35607739
[TBL] [Abstract][Full Text] [Related]
4. A case report of Guillain-Barré syndrome in a pregnant woman infected by COVID-19.
Mehrpour M; Arab M; Hadavand F; Khalafi M; Khalafi M
Acta Neurol Belg; 2021 Aug; 121(4):1079-1080. PubMed ID: 34080170
[No Abstract] [Full Text] [Related]
5. Guillain-Barré Syndrome After COVID-19 Infection in Korea: A Case Series.
Ryoo N; Son H; Kim JH; Bae DW; An JY
J Korean Med Sci; 2024 Feb; 39(5):e48. PubMed ID: 38317448
[TBL] [Abstract][Full Text] [Related]
6. A unique association of bifacial weakness, paresthesia and vestibulocochlear neuritis as post-COVID-19 manifestation in pregnant women: a case report.
Aasfara J; Hajjij A; Bensouda H; Ouhabi H; Benariba F
Pan Afr Med J; 2021; 38():30. PubMed ID: 33777298
[TBL] [Abstract][Full Text] [Related]
7. [COVID-19-associated Guillain-Barré syndrome in infectious period: a case report].
Nishida K; Sakashita K; Uchibori A; Chiba A; Futamura N
Rinsho Shinkeigaku; 2022 Apr; 62(4):293-297. PubMed ID: 35354729
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
Front Immunol; 2022; 13():894872. PubMed ID: 35924236
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome associated with COVID-19 disease.
Korem S; Gandhi H; Dayag DB
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32958554
[TBL] [Abstract][Full Text] [Related]
10. Post-COVID-19 Guillain-Barré Syndrome: A case report from Oman.
Al-Zadjali MM; Al Shibli E; Al Maskari M; Gujjar AR; Al Asmi A
Sultan Qaboos Univ Med J; 2022 Aug; 22(3):409-412. PubMed ID: 36072070
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré Syndrome and multiple lacunar infarcts in a COVID-19 patient.
Suci YD; Rosyid AN; Wulaa NL; Alamsyah M; Irmayani Ak ; Bachrun T
J Infect Dev Ctries; 2023 Nov; 17(11):1641-1646. PubMed ID: 38064394
[TBL] [Abstract][Full Text] [Related]
12. Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.
Wada S; Nagasaki Y; Arimizu Y; Shimo M; Matsukuma Y; Okamoto M; Yoshida S; Ohashi I; Hashimoto G; Kuwashiro T; Yasaka M; Okada Y
Intern Med; 2020 Sep; 59(17):2187-2189. PubMed ID: 32713924
[TBL] [Abstract][Full Text] [Related]
13. Concurrence of Guillain-Barré syndrome and primary biliary cholangitis not related to SARS-CoV-2: Case report.
Segura-Chávez D; Tagle-Lostaunau I; Sifuentes-Monge J; Aquino-Peña F
Medwave; 2023 Apr; 23(3):. PubMed ID: 37115660
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up.
Papri N; Hayat S; Mohammed A; Afsar MNA; Hasan I; Rahman A; Jahan I; Islam Z
J Neuroimmunol; 2021 Jul; 356():577590. PubMed ID: 33957540
[TBL] [Abstract][Full Text] [Related]
15. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.
Akçay N; Menentoğlu ME; Bektaş G; Şevketoğlu E
J Med Virol; 2021 Sep; 93(9):5599-5602. PubMed ID: 33851741
[TBL] [Abstract][Full Text] [Related]
16. Intensive care management in guillain barré syndrome accompanying prolonged Covid-19-A case report.
Toy E; Kart K
Niger J Clin Pract; 2022 Feb; 25(2):200-202. PubMed ID: 35170448
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré Syndrome after Novel Coronavirus Disease 2019.
Yakoby J; Litvak I; Yu E
J Emerg Med; 2021 Oct; 61(4):e67-e70. PubMed ID: 34103203
[TBL] [Abstract][Full Text] [Related]
18. Post COVID-19 Guillain-Barre syndrome presents as sensory dominant neuropathy with reversible conduction failure.
AlTahan AM; AlAnazi MH; AlTahan FA; AlAbandi FA
Neurosciences (Riyadh); 2023 Jan; 28(1):57-61. PubMed ID: 36617454
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections.
Meidaninikjeh S; Sabouni N; Taheri M; Borjkhani M; Bengar S; Majidi Zolbanin N; Khalili A; Jafari R
Viral Immunol; 2022 Jul; 35(6):404-417. PubMed ID: 35766944
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology?
Guilmot A; Maldonado Slootjes S; Bissay V; Dubuisson N; de Broglie C; Gille M
Acta Neurol Belg; 2022 Jun; 122(3):703-707. PubMed ID: 34476752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
